Comparative Effectiveness of Statins Vs PCSK9 Inhibitors in High-Risk CV patients. Indus Journal of Bioscience Research, [S. l.], v. 3, n. 4, p. 777–781, 2025. DOI: 10.70749/ijbr.v3i4.1238. Disponível em: https://ijbr.com.pk/IJBR/article/view/1238. Acesso em: 14 aug. 2025.